SCHEMBL19953102

SCHEMBL19953102

CC(=O)C(=[N+]=[N-])[PH](=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23646967 0.73
Butanedione SCHEMBL4889052 0.66 TSHR (0.58)
SCHEMBL7904200 0.62
Butanedione SCHEMBL4879228 0.62 TSHR (0.64)
SCHEMBL5846213 0.61
SCHEMBL5836218 0.61
SCHEMBL27808753 0.60
SCHEMBL9367389 0.57
Butanedione SCHEMBL3398297 0.57
Acetic Acid SCHEMBL18063114 0.55

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018048969-A1 MULTI-TARGETED HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2018-03-15 WO disclosed